Status:
RECRUITING
fNIRS-BCI Neurofeedback in Stroke Rehabilitation
Lead Sponsor:
The Hong Kong Polytechnic University
Collaborating Sponsors:
Tung Wah Hospital, Queen Mary Hospital and University Hospital RWTH Aachen/RWTH Aachen University
Conditions:
Stroke
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Objectives: 1) To compare the effects of closed-loop brain-computer interface (BCI) driven observational imitation training versus sham BCI open-loop observational imitation training on improving uppe...
Detailed Description
Objectives: 1) To compare the effects of closed-loop brain-computer interface (BCI) driven observational imitation training versus sham BCI open-loop observational imitation training on improving uppe...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- unilateral upper extremity motor deficits caused by ischemic stroke, confirmed by medical documents such as discharge summary and/or neuroimaging examinations.
- chronic phase of stroke, i.e., time after stroke onset more than six months.
- aged between 18 and 75 years old.
- with mildly-to-moderately impaired upper limb functional activity that is stratified according to the levels 3-7 in the Functional Test for the Hemiplegic Upper Extremity.
- able to give informed written consent to participate in the study.
- able to read and understand traditional Chinese.
- Exclusion Criteria
- previous diagnosis of any neurological disease excluding ischemic stroke.
- presence of any sign of cognitive problems (The Montreal cognitive assessment Hong Kong version\<22/30).
- Severe spasticity measured by the Modified Ashworth Scale score\>2 in the hand, wrist or elbow extensor muscle in the hemiparetic upper extremity.
- with other notable impairments of the upper limb not caused by stroke (e.g., bone fracture in the past year, congenital deformity, or other impairments).
- current participation in any other treatment programme or clinical study involving exercise, non-invasive brain stimulation, or BCI/neurofeedback.
Exclusion
Key Trial Info
Start Date :
December 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06503484
Start Date
December 12 2024
End Date
December 31 2025
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jack Jiaqi Zhang
Hong Kong, Hong Kong, Hong Kong, 000000